| For: | Cencini E, Fabbri A, Mecacci B, Bocchia M. Role of lenalidomide in the treatment of peripheral T-cell non-Hodgkin lymphomas. World J Clin Oncol 2021; 12(10): 882-896 [PMID: 34733611 DOI: 10.5306/wjco.v12.i10.882] |
|---|---|
| URL: | https://www.wjgnet.com/2218-4333/full/v12/i10/882.htm |
| Number | Citing Articles |
| 1 |
Rodrigo Naser, Ignacio Domínguez, Alejandro Revello, Marcelo Abarca. ¿Será esta plasmocitosis una neoplasia de células plasmáticas? La importancia en la distinciÓn entre una plasmocitosis reactiva y una clonal: reporte de un caso. Revista Médica Clínica Las Condes 2025; 36(1): 36 doi: 10.1016/j.rmclc.2025.01.006
|
| 2 |
Fatih Tok, Burçin İrem Abas, Faika Başoğlu, Özge Çevik, Sevgi Karakuş, Abdulilah Ece. Synthesis, Biological Evaluation and in Silico Studies of Novel Urea/Thiourea Derivatives of Lenalidomide. Journal of Biochemical and Molecular Toxicology 2024; 38(12) doi: 10.1002/jbt.70079
|
| 3 |
Süreyya Yiğit Kaya, Rima Akil, Gülşah Akyol, Amir Hossein Abedi, Serhat Çelik, Leylagül Kaynar. Long-Term Response to Single-Agent Lenalidomide in an Elderly Patient with Relapsed Hepatosplenic T-Cell Lymphoma. Turkish Journal of Hematology 2025; doi: 10.4274/tjh.galenos.2025.2025.0252
|
